Home/Hedge Fund Intelligence/BridgeBio Oncology Therapeutics, Inc.
Nasdaq: BBOTStockForm 13F30 Jun 2026

Hedge funds that hold BridgeBio Oncology Therapeutics, Inc. New Nasdaq: BBOT

New · CUSIP 107924102 · who reports it, how much, and how much it matters to them

16 of the 720 hedge fund managers we track reported shares of BridgeBio Oncology Therapeutics, Inc. (Nasdaq: BBOT) on Form 13F for 30 June 2026. Between them they reported USD 204m. The largest position belongs to Cormorant Asset Management, at USD 136m.

Managers reporting it16of 720 we track
Value they reportUSD 204mshares only, 30 Jun 2026
Funds they run184with a file on PPLI.com
Largest positionUSD 136mCormorant Asset Management
Typical weight0.0%median share of a manager's book
Heaviest weight7.0%Cormorant Asset Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

16 managers, USD 204m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports BridgeBio Oncology Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Cormorant Asset Management1 fund on PPLI.comUSD 136m7.0%
2ECOR1 Capital3 funds on PPLI.comUSD 22m1.0%
3Citadel Advisors32 funds on PPLI.comUSD 20m0.0%
4Armistice Capital1 fund on PPLI.comUSD 13m0.2%
5Sphera Funds Management1 fund on PPLI.comUSD 3.5m0.5%
6Adage Capital Management1 fund on PPLI.comUSD 3m0.0%
7Casdin Capital3 funds on PPLI.comUSD 2.2m0.1%
8Sio Capital Management4 funds on PPLI.comUSD 995,0000.2%
9Millennium Management6 funds on PPLI.comUSD 804,0000.0%
10Moore Capital Management7 funds on PPLI.comUSD 762,0000.0%
11Brevan Howard Capital Management39 funds on PPLI.comUSD 691,0000.0%
12Renaissance Technologies13 funds on PPLI.comUSD 447,0000.0%
13Two Sigma Investments35 funds on PPLI.comUSD 202,0000.0%
14Squarepoint Ops7 funds on PPLI.comUSD 150,0000.0%
15Schonfeld Strategic Advisors30 funds on PPLI.comUSD 87,6590.0%
16The Quarry1 fund on PPLI.comUSD 1,5010.0%
Next: where it matters most
Where it matters most

For Cormorant Asset Management it is 7.0% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Cormorant Asset ManagementUSD 136m7.0%
2ECOR1 CapitalUSD 22m1.0%
3Sphera Funds ManagementUSD 3.5m0.5%
4Sio Capital ManagementUSD 995,0000.2%
5Armistice CapitalUSD 13m0.2%
6Casdin CapitalUSD 2.2m0.1%
7Moore Capital ManagementUSD 762,0000.0%
8Brevan Howard Capital ManagementUSD 691,0000.0%
9Adage Capital ManagementUSD 3m0.0%
10Citadel AdvisorsUSD 20m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds BridgeBio Oncology Therapeutics, Inc.

What is the ticker symbol of BridgeBio Oncology Therapeutics, Inc.?

BridgeBio Oncology Therapeutics, Inc. trades under the symbol BBOT on the Nasdaq. Its CUSIP, the code used on Form 13F, is 107924102.

Which hedge funds own BridgeBio Oncology Therapeutics, Inc. (Nasdaq: BBOT)?

16 of the 720 hedge fund managers PPLI.com tracks reported BridgeBio Oncology Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Cormorant Asset Management (USD 136m), ECOR1 Capital (USD 22m), Citadel Advisors (USD 20m), Armistice Capital (USD 13m) and Sphera Funds Management (USD 3.5m).

How many hedge funds hold BridgeBio Oncology Therapeutics, Inc.?

16 managers in our coverage reported it, and between them they run 184 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on BridgeBio Oncology Therapeutics, Inc.?

Cormorant Asset Management, where the position was 7.0% of the reported 13F book at 30 June 2026.

Does this show who is short BridgeBio Oncology Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with BridgeBio Oncology Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.